Routine

Iron deficiency anaemia - work-up & management

IDA work-up · Haematology / Oncology
Physician-written · Verified by three sets of doctors · Reviewed November 2026

Bedside summary

Microcytic hypochromic anaemia from depleted iron stores, most often chronic blood loss (GI or menstrual) or malabsorption. Diagnosis rests on low ferritin; management combines iron replacement with identifying and treating the cause.

Red flags

  • Unexplained IDA in man or postmenopausal woman (occult GI malignancy)
  • Weight loss, rectal bleeding, change in bowel habit or abdominal mass
  • Dysphagia or epigastric pain
  • Severe symptomatic anaemia (angina, breathlessness at rest)
  • Failure to respond to adequate oral iron

Assessment

Differential diagnosis

  • Thalassaemia trait
  • Anaemia of chronic disease
  • Sideroblastic anaemia
  • Lead poisoning
  • Combined deficiency (iron plus B12/folate)

Investigations

  • FBC with indices and film (microcytic, low MCV/MCH, high RDW)
  • Ferritin (low confirms; note acute-phase elevation)
  • Transferrin saturation and iron studies if ferritin equivocal
  • Reticulocyte count and CRP
  • Coeliac serology (anti-TTG)
  • Faecal immunochemical test / OGD + colonoscopy for unexplained IDA
  • Urinalysis for haematuria

Management

  • Confirm true iron deficiency with ferritin; if inflammation present use transferrin saturation <20% or soluble transferrin receptor
  • Determine cause: menstrual/pregnancy history, GI symptoms, NSAID use, diet
  • Refer for urgent OGD and colonoscopy in any man or postmenopausal woman with unexplained IDA (2-week-wait pathway)
  • Send coeliac serology in all unexplained cases
  • Start oral iron first line unless intolerant or malabsorption
  • Prescribe one tablet daily or alternate-day dosing to improve absorption and reduce side effects
  • Recheck Hb at 2-4 weeks expecting a rise of ~20 g/L; continue iron 3 months after Hb normalises to replenish stores
  • Use IV iron if oral intolerance, non-adherence, ongoing losses outpacing absorption, CKD, IBD, or need for rapid correction
  • Investigate and treat the underlying source of loss
  • Safety-net and arrange follow-up FBC/ferritin to confirm store repletion

Drugs & doses

Ferrous sulfate 200 mg (65 mg elemental) PO once daily or alternate days
Ferrous fumarate 210 mg PO once daily (alternative)
Ferric carboxymaltose up to 20 mg/kg (max 1000 mg) IV infusion per dose
Ferric derisomaltose up to 20 mg/kg IV as single infusion

Disposition

Outpatient / primary care management; fast-track GI referral for unexplained IDA; haematology only for diagnostic uncertainty or refractory cases.

Complications & pitfalls

  • High-output cardiac failure in severe chronic anaemia
  • Missed GI malignancy if work-up incomplete
  • Oral iron GI intolerance and non-adherence
  • Rare hypophosphataemia with ferric carboxymaltose
  • Anaphylaxis (very rare) with IV iron

Exam pearls

  • Alternate-day single-dose oral iron increases fractional absorption by minimising hepcidin rise
  • A normal ferritin does not exclude deficiency during inflammation; check transferrin saturation
  • Rise in reticulocytes within a week confirms response to iron
  • IV iron corrects stores in one or two visits and is preferred in CKD and IBD
  • Always ask about and treat the cause, not just the number

Disclaimer: Educational decision support for qualified clinicians and students — not a substitute for clinical judgement, local protocols or a full drug reference. Confirm every dose and contraindication against your formulary before prescribing.